Results 111 to 120 of about 7,344,469 (193)

TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas' heart disease. [PDF]

PLoS Negl Trop Dis, 2019
Ferreira RR, Abreu RDS, Vilar-Pereira G, Degrave W, Meuser-Batista M, Ferreira NVC, da Cruz Moreira O, da Silva Gomes NL, Mello de Souza E, Ramos IP, Bailly S, Feige JJ, Lannes-Vieira J, de Araújo-Jorge TC, Waghabi MC.   +14 more
europepmc   +1 more source

Diversity of Trypanosoma cruzi stocks and clones derived from Chagas disease patients: I-Behavioral characterization in vitro

Revista da Sociedade Brasileira de Medicina Tropical, 1997
In this study, we isolated Trypanosoma cruzi from chronic Chagas heart disease and from megaesophagus patients. The parasite stock hSLU239 (heart disease) yielded clones h1 and h2, whereas stock mSLU142 (megaesophagus) yielded clones m1, m2, m3 and m4 ...
Lauria-Pires L., Santana J.M., Tavares F.S., Teixeira A.R.L.   +3 more
doaj  

Chagas' disease reactivation after heart transplantation: Efficacy of allopurinol treatment

, 1996
Background: Chagas' disease is a parasitic infection that provokes a severe form of dilated cardiomyopathy. In the initial experience with heart transplantation with Chagas' disease, a high rate of acute reactivation has been reported.
Almeida, Dirceu Rodrigues de [UNIFESP], Branco, João Nelson Rodrigues [UNIFESP], Pereira, Carlos Alberto Pires [UNIFESP], Vianna, Paula Vilhena Carnevale [UNIFESP], Buffolo, Enio [UNIFESP], Martinez Filho, Eulogio Emilio [UNIFESP], Correa, Luci [UNIFESP], Carvalho, Antonio Carlos [UNIFESP]   +7 more
core  

Cardiac and Digestive Forms of Chagas Disease: An Update on Pathogenesis, Genetics, and Therapeutic Targets

Mediators of Inflammation
Chagas disease, caused by the protozoan parasite Trypanosoma cruzi (T. cruzi), is a neglected disease affecting around 6 million people, with no effective antiparasitic drugs or vaccines.
Amanda Farage Frade, Hélléa Guérin, Joao Paulo Silva Nunes, Luiz Felipe Souza e Silva, Vinicius Moraes de Paiva Roda, Rafael Pedro Madeira, Pauline Brochet, Pauline Andrieux, Jorge Kalil, Christophe Chevillard, Edecio Cunha-Neto   +10 more
doaj   +1 more source

Burden of heart disease in Ohio 2009

, 2010
Title from PDF cover; author statement from p. 2 of cover (viewed on May 19, 2011).; "Created: 1/6/2010 ... ; Modified: 1/11/2010 ..."--Document properties screen.; Includes bibliographical references.Key findings -- Risk factors, prevalence and access ...
DeFiore-Hyrmer, Jolene.
core  

Cardiac Fibrosis and Changes in Left Ventricle Function in Patients with Chronic Chagas Heart Disease. [PDF]

Arq Bras Cardiol, 2021
Santos JBF, Gottlieb I, Tassi EM, Camargo GC, Atié J, Xavier SS, Pedrosa RC, Saraiva RM.   +7 more
europepmc   +1 more source

Serum Cytokine Levels and Heart Rate Variability in the Frequency Domain in Patients With Chronic Chagas Heart Disease. [PDF]

Cureus
Bestetti RB, Dellalibera-Joviliano R, Faria Junior M, Furlan Daniel RA, Domingos CC.   +4 more
europepmc   +1 more source

Author Correction: Discovery of circulating miRNAs as biomarkers of chronic Chagas heart disease via a small RNA-Seq approach. [PDF]

Sci Rep
Villar SR, Herreros-Cabello A, Callejas-Hernández F, Maza MC, Del Moral-Salmoral J, Gómez-Montes M, Rodríguez-Angulo HO, Carrillo I, Górgolas M, Bosch-Nicolau P, Molina I, Pérez-Molina JA, Monge-Maillo B, Bottasso OA, Beloscar J, Pérez AR, Fresno M, Gironès N.   +17 more
europepmc   +1 more source

Association study between CCR2-CCR5 genes polymorphisms and chronic Chagas heart disease in Wichi and in admixed populations from Argentina. [PDF]

PLoS Negl Trop Dis, 2019
Juiz NA, Estupiñán E, Hernández D, Garcilazo A, Chadi R, Morales Sanfurgo G, Schijman AG, Longhi SA, González CI.   +8 more
europepmc   +1 more source

Discovery of circulating miRNAs as biomarkers of chronic Chagas heart disease via a small RNA-Seq approach. [PDF]

Sci Rep
Villar SR, Herreros-Cabello A, Callejas-Hernández F, Maza MC, Del Moral-Salmoral J, Gómez-Montes M, Rodríguez-Angulo HO, Carrillo I, Górgolas M, Bosch-Nicolau P, Molina I, Pérez-Molina JA, Monge-Maillo B, Bottasso OA, Beloscar J, Pérez AR, Fresno M, Gironès N.   +17 more
europepmc   +1 more source